Human Longevity Reappoints Craig Venter as CEO
Human Longevity Inc. founder Craig Venter has been reappointed as CEO replacing Cynthia Collins, who only joined the company in January.
“The company and board thank Collins for her service at HLI over the last year and wish her the very best in her future endeavours,” the company said. No further details were given for why Collins is moving on.
The departure was accompanied by several other of the company’s senior management, according to an article by Fortune, which originally reported on the shakeup.
In addition, Saturnino “Nino” Fanlo, its Chief Financial Officer, has also been named Chief Operations Officer, the La Jolla-based company said in a statement.
Human Longevity said it is “streamlining” its efforts in favour of focusing on its clinical research arm, Health Nucleus.
Health Nucleus uses genomics and other bio-data to map the health of wealthy individuals, giving them early warning of major diseases. The goal is to increase the “healthspan,” or healthy lifespan.
The system provides a cutting-edge model which may become the norm for mainstream healthcare as the technologies mature.
“We are at a pivotal point where refocusing our efforts and our strong team will allow us to continue to drive this positive impact on health more broadly,” Venter said in the statement.